Carlsmed(NASDAQ) CARL

Market Cap$374.59M

Since IPO (2025)-5%

5 YearN/A

1 Year+4%

1 Month+13%

$13.66

-0.51%

-0.07Today

After hours$13.69+$0.03 (+0.22%)

Carlsmed last closing stock price
Metric	Price	Date
Last close	USD 13.72	2026-08-12

Carlsmed stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+1.18%	USD 13.56	2026-08-05
1 month	+13.29%	USD 12.11	2026-07-13
3 month	+27.51%	USD 10.76	2026-05-14
Year to date	+11.09%	USD 12.35	2025-12-31
1 year	+3.55%	USD 13.25	2025-08-12
Since inception	-5.31%	USD 14.50	2025-07-23

Carlsmed Financials at a Glance

Market Cap

$374.59M

Revenue (TTM)

$63.30M

Net Income (TTM)

-$36.35M

EPS (TTM)

-$1.36

P/E Ratio

-10.13

Dividend

$0.00

Beta (Volatility)

1.12 (Average)

Dividend

$0.00

Beta (Volatility)

1.12 (Average)

Price

$13.66

Volume

150,068.303

Open

$13.67

Price

$13.66

Volume

150,068.303

Open

$13.67

Previous Close

$13.72

Daily Range

$13.30 - $14.02

52-Week Range

$8.50 - $17.19

Estimated Earnings Date

Nov 5, 2026

Dividend

$0.00

Beta (Volatility)

1.12 (Average)

Price

$13.66

Volume

150,068.303

Open

$13.67

Previous Close

$13.72

Daily Range

$13.30 - $14.02

52-Week Range

$8.50 - $17.19

Estimated Earnings Date

Nov 5, 2026

CARL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Carlsmed

Carlsmed makes 3D-printed parts for people having back surgery. These parts help surgeons fix spines using a patient's unique shape. The company uses software to plan surgeries before they start.

Custom Parts for Better Backs

aprevo Technology Platform: Personalized surgical plans and 3D-printed implants for spine fusion; uses software to fit each patient's anatomy.
aprevo Lumbar: Implants designed for the lower back to correct spinal deformities and degenerative conditions.
aprevo Cervical: Medical implants for neck surgery; launched commercially in December 2025 following 2024 regulatory clearance.
corra Cervical Plating: Support systems for neck fusions; expected to launch fully by the end of 2026.

Growing Beyond the Lower Back

Launched the aprevo Cervical system in December 2025 to expand into neck surgery procedures.
Received regulatory clearance for the corra Cervical Plating System in December 2025.
Completed the first surgery using the corra system at the University of California San Francisco in February 2026.
Introduced an updated digital production system in November 2024 to speed up manufacturing times.

Intelligence Meets the Operating Room

Using computer algorithms, the company creates a surgical plan and custom hardware for every individual patient. Hospitals may receive extra Medicare payments, called New Technology Add-On Payments, when using the neck surgery platform.

Performance by the Numbers

Revenue hit $16.1 million in Q1 2026, up 58.2% from $10.2 million in Q1 2025.
Gross profit reached $12.4 million in Q1 2026, up 62.7% year-over-year.
Net loss was $8.7 million in Q1 2026, which worsened from a loss of $5.7 million in Q1 2025.
Free cash flow was negative $13.1 million in Q1 2026, worsening from negative $8.4 million in Q1 2025.

Bottom Line

Carlsmed has evolved from a research firm into a commercial provider of software-driven surgical tools for the entire spine. Its growth relies on replacing standard, mass-produced medical parts with items built for a specific patient.

AI Generated • May 13, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

127

CEO

Mike Cordonnier

Website

www.carlsmed.com

Headquarters

Carlsbad, CA 92008, US

CARL Financials

Key Financial Metrics (TTM)

Gross Margin

76.63%

Operating Margin

-61.09%

Net Income Margin

-57.42%

Return on Equity

-38.06%

Return on Capital

-26.29%

Return on Assets

-30.75%

Earnings Yield

-9.87%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$374.59M

Shares Outstanding

27.30M

Volume

150.07K

Avg. Volume

172.27K

Financials (TTM)

Gross Profit

$48.50M

Operating Income

-$38.67M

EBITDA

-$24.22M

Operating Cash Flow

-$34.15M

Capital Expenditure

-$58.00K

Free Cash Flow

-$34.20M

Cash & ST Invst.

$89.22M

Total Debt

$21.92M

Carlsmed Performance Analysis

Carlsmed annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2023	2023-12-31	USD 13,778,000	N/A
2024	2024-12-31	USD 27,165,000	97.2%
2025	2025-12-31	USD 50,511,000	85.9%

Carlsmed sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	8.2%
Q4	2025-12-31	16.0%
Q1	2026-03-31	6.3%
Q2	2026-06-30	17.5%

Carlsmed annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2023	2023-12-31	USD -0.71	N/A
2024	2024-12-31	USD -0.94	31.5%
2025	2025-12-31	USD -1.14	21.2%

Carlsmed sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	72.8%
Q4	2025-12-31	37.5%
Q1	2026-03-31	-28.0%
Q2	2026-06-30	-21.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$18.94M

+56.7%

Gross Profit

$14.54M

+64.0%

Gross Margin

76.78%

N/A

Market Cap

$374.59M

N/A

Market Cap/Employee

$2.95M

N/A

Employees

127

N/A

Net Income

-$10.51M

-55.3%

EBITDA

$313.00K

+104.9%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

$89.22M

+166.6%

Total Debt

$21.92M

+23.8%

Accounts Receivable

$13.78M

+41.8%

Inventory

$2.28M

+113.0%

Long Term Debt

$21.21M

+23.8%

Short Term Debt

$703.00K

+23.1%

Return on Assets

-30.75%

N/A

Return on Invested Capital

-36.54%

N/A

Free Cash Flow

-$7.48M

+1.4%

Operating Cash Flow

-$7.36M

-4.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,754.29+0.00%

^DJIDJI

^DJIDJI$53,811.30+0.00%

^IXICNASDAQ

^IXICNASDAQ$26,624.04+0.01%

BTCBitcoin

BTCBitcoin$63,366.00-0.00%

SPCXSPCX

SPCXSPCX$146.62+0.10%

AAPLAAPL

AAPLAAPL$301.43-0.01%

AMZNAMZN

AMZNAMZN$268.41-0.01%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$146.15+0.10%

SMCISuper Micro Computer

SMCISuper Micro Computer$37.61+0.19%

INTCIntel

INTCIntel$100.95+0.03%

NOKNokia

NOKNokia$10.32+0.09%

NVDANvidia

NVDANvidia$224.09+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$8.05-0.03%

CRWVCoreWeave

CRWVCoreWeave$107.73+0.19%

Questions About CARL

What is the current price of Carlsmed?

Carlsmed is trading at $13.72 per share.

What is the 52-week range for Carlsmed?

Over the past 52 weeks, Carlsmed has traded between $8.50 and $17.19.

How much debt does Carlsmed have?

As of the most recent reporting period, Carlsmed reported total debt of $21.92M.

How much cash does Carlsmed have on hand?

Carlsmed reported $46.34M in cash and cash equivalents in its most recent financial results.

What is Carlsmed’s dividend yield?

Carlsmed does not currently have a dividend yield.

Carlsmed(NASDAQ) CARL

Carlsmed Financials at a Glance

CARL News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Carlsmed

Custom Parts for Better Backs

Growing Beyond the Lower Back

Intelligence Meets the Operating Room

Performance by the Numbers

Bottom Line

CARL Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Carlsmed Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CARL

What is the current price of Carlsmed?

What is the 52-week range for Carlsmed?

How much debt does Carlsmed have?

How much cash does Carlsmed have on hand?

What is Carlsmed’s dividend yield?

Premium Investing Services